Amino acids interactions and binding energy describe that ABT-199 binds to ALK^Mutant. by Richard Junior Zapata Dongo (17912565)

Subjects:

Western blot analysis of drug combinations. by Richard Junior Zapata Dongo (17912565)

Subjects:

ALKL1196M –ABT199 interactions. by Richard Junior Zapata Dongo (17912565)

Subjects:

Overexpression of miR-1247-3p promoted apoptosis and inhibited resistance in drug-resistant cells. by Dequan Wang (6007007)

Subjects:

ALK^wt–ABT199 interactions. by Richard Junior Zapata Dongo (17912565)

Subjects:

BCL2 protein keeps their expression in different conditions treatment nevertheless each EML4-ALK cell modells exhibit variable expression. by Richard Junior Zapata Dongo (17912565)

Subjects:

ALK inhibitors (Positive control) and ABT199 (Proposed binding) in complex with the ALK active side. by Richard Junior Zapata Dongo (17912565)

Subjects:

Effect of miR-1247-3p on survival in colorectal cancer patients. by Dequan Wang (6007007)

Subjects:

BCL2 antiapoptotic protein exhibits heterogeneous expression in Ba/F3 EML4-ALK^mutants. by Richard Junior Zapata Dongo (17912565)

Subjects:

Loewe synergy-antagonism score analysis shows additive and synergistic effects after ALKi and ABT-199 combination treatment. by Richard Junior Zapata Dongo (17912565)

Subjects:

S1 Raw images - by Dequan Wang (6007007)

Subjects:

Introduction to the dataset. by Dequan Wang (6007007)

Subjects:

Downregulation of miR-1247-3p inhibited apoptosis and reduced chemosensitivity in cells. by Dequan Wang (6007007)

Subjects:

Negative (Prednisone) and basal (ATP) control compounds binding to ALK protein. by Richard Junior Zapata Dongo (17912565)

Subjects:

miR-1247-3p was downregulated in tissues of patients with CRC and was associated with prognosis and drug resistance. by Dequan Wang (6007007)

Subjects:

S1 Graphical abstract - by Aman Goyal (19231397)

“…</p><p>Conclusions</p><p>Our analysis showed a significant decrease in mortality from paroxysmal tachycardia since 1999, although there has been a slight increase in recent years. …”

Key characteristics of non-healed DU wound records at adopted branches in 2022 and 2023. by Heba Tallah Mohammed (2822432)

Subjects:

Overall characteristics of wound records at adopted branches in 2022 and 2023. by Heba Tallah Mohammed (2822432)

Subjects:

FDA-approved reference marker and capturing wound image. by Heba Tallah Mohammed (2822432)

Subjects:

Longitudinal assessment of animal weights and tumor metrics. by Robert Botelho (20308297)

Subjects: